Financial Perspectives’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-28
Closed -$4.08K 675
2021
Q3
$4.08K Hold
28
﹤0.01% 540
2021
Q2
$5.48K Sell
28
-5,040
-99% -$912K ﹤0.01% 529
2021
Q1
$28K Buy
+5,068
New +$875K ﹤0.01% 578

Other funds holding TXG

Financial Perspectives's TXG Position: Q4 2021 in Review

Financial Perspectives sold out of 10x Genomics (TXG) in Q4 2021, closing a stake of 28 shares — an estimated $4.08K sold.

Financial Perspectives first reported a position in TXG in Q1 2021 and held it in 3 quarters. The position peaked at $28K in Q1 2021. 365 funds tracked by Wall St. Rank hold TXG as of Q4 2021.

  • Financial Perspectives reported no remaining 10x Genomics position as of Q4 2021 after selling out during the quarter.
  • Financial Perspectives sold 28 10x Genomics shares in Q4 2021, an estimated $4.08K.
  • Financial Perspectives first reported a position in 10x Genomics in Q1 2021 and held it in 3 quarters.
  • Financial Perspectives's 10x Genomics position peaked at $28K in Q1 2021.
  • 365 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2021.

Based on Financial Perspectives's 13F filing for Q4 2021, filed 10 Jan 2024.